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Background. Mucopolysaccharidosis (MPS) IIIB (Sanfilippo Syndrome type B) is caused by a deficiency in the lysosomal
enzyme N-acetyl-glucosaminidase (Naglu). Children with MPS IIIB develop disturbances of sleep, activity levels, coordination,
vision, hearing, and mental functioning culminating in early death. The murine model of MPS IIIB demonstrates lysosomal
distention in multiple tissues, a shortened life span, and behavioral changes. Principal Findings. To more thoroughly assess
MPS IIIB in mice, alterations in circadian rhythm, activity level, motor function, vision, and hearing were tested. The
suprachiasmatic nucleus (SCN) developed pathologic changes and locomotor analysis showed that MPS IIIB mice start their
daily activity later and have a lower proportion of activity during the night than wild-type controls. Rotarod assessment of
motor function revealed a progressive inability to coordinate movement in a rocking paradigm. Purkinje cell counts were
significantly reduced in the MPS IIIB animals compared to age matched controls. By electroretinography (ERG), MPS IIIB mice
had a progressive decrease in the amplitude of the dark-adapted b-wave response. Corresponding pathology revealed
shortening of the outer segments, thinning of the outer nuclear layer, and inclusions in the retinal pigmented epithelium.
Auditory-evoked brainstem responses (ABR) demonstrated progressive hearing deficits consistent with the observed loss of
hair cells in the inner ear and histologic abnormalities in the middle ear. Conclusions/Significance. The mouse model of MPS
IIIB has several quantifiable phenotypic alterations and is similar to the human disease. These physiologic and histologic
changes provide insights into the progression of this disease and will serve as important parameters when evaluating various
therapies.
Citation: Heldermon CD, Hennig AK, Ohlemiller KK, Ogilvie JM, Herzog ED, et al (2007) Development of Sensory, Motor and Behavioral Deficits in the
Murine Model of Sanfilippo Syndrome Type B. PLoS ONE 2(8): e772. doi:10.1371/journal.pone.0000772
INTRODUCTION
Mucopolysaccharidosis III (MPS III, Sanfilippo Syndrome) is
a lysosomal storage disease that results from a deficiency in any of
four lysosomal enzymes required for the complete degradation of
proteoglycans containing heparan sulfate. There are four subtypes
of Sanfilippo disease: type A – sulfamidase deficient; type B – a-N-
acetylglucosaminidase deficient; type C – acetyl-CoA: a-N-
glucosaminide transferase deficient; type D – glucosamine-6-
sulfatase deficient. Affected children appear normal in the first few
years of life, but become aggressive and hyperactive [1,2], develop
sleep disturbances [3,4] and have severe developmental delays as
they age. Eventually, they regress mentally and develop loss of
hearing [5], vision [6,7] and balance. The children lose social
interaction, become unable to ambulate and die of respiratory
complications, heart failure or infection.
Characteristic pathologic changes are seen in the brain and
other organs of MPS III patients, including lysosomal inclusions,
cerebellar atrophy with loss of Purkinje cells [8,9,10], cortical and
corpus callosum atrophy with white matter changes [11,5], retinal
pigmented epithelium (RPE) pigmentation loss, and photoreceptor
degeneration [7,12]. Usually symptom progression occurs over
a decade starting around age 3–5. However, indolent adult onsets
and rapidly progressive early onsets have been described
[13,14,15,16].
Therapy for the disease currently consists of supportive care.
Antibiotics are given for infections, antipsychotics or sedatives for
the behavior disturbances, and physical therapy for decreased
mobility.[17]
A mouse model of MPS IIIB was created by disruption of the
a-N-acetylglucosaminidase gene. Histopathologically, the mouse
model demonstrated accumulation of abnormal lysosomal inclu-
sions in multiple tissues and neuronal cell loss with concomitant
astrocyte activation [18,19]. The accumulation of heparan sulfate
and gangliosides GM2 and GM3 in visceral organs and the brain
was also demonstrated [20]. Clinical correlates of the histopath-
ologic abnormalities included decreased life span, and changes in
anxiety response and activity using open field testing. Interestingly,
two different groups have assessed activity level using open field
tests and demonstrated opposite trends [20,21]. These groups also
assessed anxiety and obtained slightly different results with
different assays. The affect of vision and hearing loss on these
tests was not determined.
We performed a battery of longitudinal tests of coordination,
circadian rhythm, hearing, and vision, and correlated these tests
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phenotypic effects in the mouse and demonstrate that the MPS
IIIB mouse model has similar behavioral and sensory deficits to
human MPS IIIB. The MPS IIIB mouse should serve as
a reasonable model for evaluating therapeutic interventions.
MATERIALS AND METHODS
Animals
The pedigreed congenic C57BL/6 Naglu-deficient mouse strain
was acquired from The Jackson Laboratories [20], and was
maintained and expanded by strict sibling mating. Wild type (+/
+), heterozygous (+/2), and mutant (2/2) genotypes were
determined by PCR of Naglu exon 6 and the neomycin insertion
or by Naglu-4-methylumbelliferone enzyme assay [22] from tissue
samples from newborn mice. Sibling matings were mutant (2/2)
or heterozygous (+/2) males crossed with heterozygous (+/2)
females. All animal procedures were performed in accordance
with guidelines established by the Institutional Animal Care and
Use Committee at Washington University in St. Louis.
Rotarod assessment of coordination
Heterozygous and mutant mice were tested in two cohorts starting
from 31 days of age (n=18 heterozygotes and n=16 MPS IIIB)
and 217 days of age (n=7 heterozygotes and n=10 MPS IIIB)
every 3–4 weeks for 150 days. Three paradigms were used: 1.
Accelerating - acceleration over the first minute from 5 rpm to
30 rpm and maintenance of 30 rpm for the remaining 2 minutes;
2. Constant speed – continuous speed of 30 rpm for 3 minutes; 3.
Rocking - reversal of direction of rotation with each full turn of the
rod at 10 rpm for 3 minutes. Entrainment was done for 2
consecutive days with 3 attempts at each paradigm on a Rotarod
(UGO Basile, rota-rod for mice, Varese, Italy). The first testing
occurred on the third consecutive day. The length of time each
mouse remained on the rod was recorded for each of the 3
attempts at each of the three paradigms. Subsequent testing was
done at 3–4 week intervals with no subsequent entrainment. Mice
were timed for how long they could remain on the rod for each of
3 trials under each of the 3 conditions. The longest time that each
mouse remained on the rod for each condition served as the
dependent variable. The data were subjected to a repeated
measures ANOVA model that included one between-subjects
variable (Genotype) and one within-subjects variable (Ages at
testing), as well as the Huynh-Feldt adjustment of p values for
repeated measures variables containing more than two levels.
Bonferroni correction was used following multiple pairwise
comparisons.
Cerebellar Purkinje cell assessment
Cerebella from mice at ages 30 days (mutant n=6, heterozygote
n=4) and 250–350 days (mutant n=6, heterozygous n=5) were
obtained and immersion fixed in 4% paraformaldehyde in PBS
followed by 10% neutral buffered formalin. Each cerebellum was
bisected in the sagittal plane 1 micron from the midline and
embedded in paraffin. Five-micron-thick sagittal sections were
hematoxyline & eosin stained and Purkinje cells for each lobe of
the cerebellum were counted from the mid-sagittal sections at the
vermis by light microscopy. Purkinje cells were only counted if
they possessed a well defined cytoplasm, nucleus and nucleolus.
The number of Purkinje cells was recorded for each of the 10
lobules of each mouse cerebellum mid-sagittal section as previously
delineated [23]. The cell count data were also analyzed using
a repeated measures ANOVA where the model contained two
between-subjects variables (genotype and age), and one within-
subjects variable (lobe) followed by pairwise comparisons and
other relevant contrasts.
Circadian rhythm testing
Male mice (n=8 wild-type, n=9 MPS IIIB) from 70–250 days of
age were individually housed in cages outfitted with a running
wheel in light-tight ventilated chambers illuminated internally by




2 at the bottom of the cages).
We recorded wheel running activity in 1 min bins (Clocklab,
Actimetrics, Evanston, IL) while mice were exposed sequentially to
a light-dark schedule (LD; lights on at 7:00 a.m. and off at 7:00
p.m.) for 7–14 days followed by constant darkness (DD) for 7–14
days and then a skeleton photoperiod (SK) of 1 h of light per day
(lights on 1 p.m. and off at 2 p.m.) for 7 days. This sequence of LD,
DD and SK was repeated 5 times to examine the ontogeny of
circadian rhythms in mice with and without Naglu. Animals were
given fresh water and food weekly and a clean cage after 11 days in
DD.
Wheel running records were analyzed for seven parameters:
period, cycle-to-cycle (day to day) period variation, phase angle of
entrainment (delay between daily light offset and onset of activity),
rhythm amplitude (difference from average highest to average
lowest activity level), total daily activity, proportion of daily activity
in the light phase of the photocycle, and duration of daily activity.
Clocklab was used to determine the onset for each circadian cycle
as described previously [24]. Statistical comparisons were made by
2-way ANOVA in Origin (OriginLab Corp., Northampton, MA).
Suprachiasmatic nuclei (SCN)
Whole brains from MPS IIIB (n=3) and heterozygous (n=3) mice
from ages 215–353 days were obtained and immersion fixed with
2% glutaraldehyde/4% paraformaldehyde in PBS. After paraffin
embedding, one half- to one-micron-thick coronal slices through
the region of the SCN were stained with toluidine blue and
examined by light microscopy
Auditory-evoked brainstem response (ABR)
recording
Hearing in wild type and MPS IIIB mice of mixed gender (n=7–
10 of each genotype at each time point; 72 WT and 55 MPS IIIB
tested in all) were examined by ABR at 4, 9, 12.5, 16.5, 20.5, 30,
36 and 45 wks of age using Tucker-Davis Technologies System 3
Complete ABR/OAE Workstation equipped with a flashlamp
system and Medusa RA16 preamplifier and headstage, and
a Hewlett-Packard PC computer running SigGen and BioSig
software (Tucker-Davis Technologies, Alachua FL). Mice were
anesthetized (80 mg/kg ketamine, 15 mg/kg xylazine, intra-
peritoneal) and positioned dorsally in a custom head holder. Core
temperature was maintained at 37.561.0uC using a thermostati-
cally-controlled heating pad controlled by a rectal temperature
probe (FHC Inc., Bowdoinham, ME). Platinum needle electrodes
(Grass Technologies, West Warwick, RI) were inserted sub-
cutaneously just behind the test ear (recording), at the vertex
(reference), and in the back (ground). Responses were differentially
amplified and digitally filtered using BIOSIG open source software
running on a PC. Sine wave stimuli of 5, 10, 20, 40 or 56.6 kHz,
having a 5 ms total duration, including 0.5 ms rise/fall times were
generated digitally using SIGGEN in combination with an AP2
microprocessor, and converted using a 200 kHz D/A rate. Stimuli
were presented using an ES1 electrostatic speaker located 7 cm
directly lateral to either ear, concentric with the external auditory
meatus. Stimuli were presented free field and calibrated using an
Deficits in Murine MPS IIIB
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auditory meatus would normally be. Stimuli at each frequency and
level were presented 1,000 times at 20/sec. The minimum sound
pressure level required for detection of a response was determined
using a 5 dB minimum step size. The mean response, standard
deviation, and standard error of the mean were calculated for each
group of genotype and age-matched animals. Statistical analysis,
consisting of two-way ANOVA followed by Tukey pairwise
multiple comparisons, were performed using Sigma-Stat software
(SPSS, Chicago, IL).
Middle & inner ear histopathology
Because optimal preservation of middle versus inner ear involves
incompatible procedures, these were examined in different
animals, using somewhat different methods. To obtain middle
ear samples, five each of 30 wk old wild type and MPS IIIB mice
of mixed gender were sacrificed by overdose with pentobarbital
and decapitated. Intact middle and inner ears were then dissected
from the skull as a single piece connected by the dorsal plate of the
skull, and immediately immersed in cold 4% paraformaldehyde/
2% glutaraldehyde in PBS. A small hole was then made in each
auditory bulla to promote permeation of dehydration and
embedding media. Samples were fixed greater than 24 hours,
post-fixed in buffered 1% osmium tetroxide, decalcified for 30
days in 0.35 M sodium EDTA, dehydrated in an ascending
acetone series, and embedded in Epon. Left and right bullas were
then separated, sectioned in the horizontal plane at 4.0 mm, and
stained using toluidine blue.
To examine inner ears, five each of 30 wk old WT and MPS
IIIB mice of mixed gender were overdosed with pentobarbital and
decapitated. Each cochlea was rapidly isolated, immersed in cold
2.0% paraformaldehyde/2.5% glutaraldehyde in 0.1 M phos-
phate buffer (pH 7.4), and the stapes was removed. Samples were
placed in the same fixative for greater than 24 hours, and
decalcified in sodium EDTA for 72 hours. Next they were post-
fixed in buffered 1% osmium tetroxide, dehydrated in an
ascending acetone series, and embedded in Epon. Cochleae were
sectioned in the mid-modiolar plane at 4.0 mm (permitting
assessment of both cochlear duct and vestibular organs), then
stained with toluidine blue. Images taken for illustration were
captured using a Diagnostic Instruments Model 1.4.0 digital
camera controlled by Openlab
TM software, and further processed
using Canvas
TM.
A minimum of 50 sections were obtained from one or both
middle/inner ears from each animal for bright field viewing with
a Nikon Optiphot
TM light microscope. Middle ears and cochleae,
along with vestibular organs, were examined qualitatively. To
confirm an impression of loss of cochlear hair cells and afferent
neurons in the cochlear base of MPS IIIB mutant mice, 5 mid-
modiolar cochlear sections (spaced 5 sections apart) from 5 WT
and 5 mutant mice were also assessed quantitatively. To estimate
hair cell loss, the number of complete or partial hair cell profiles in
the organ of Corti (as viewed in radial section) was averaged across
5 sections in each animal. To estimate neuronal loss, nucleated
profiles within the spiral ganglion were counted within
a 3,600 mm
2 area using a calibrated grid ocular, centered over
Rosenthal’s canal, averaged over 5 sections.
Electroretinography
Flash electroretinography was performed as described previously
on wild type and MPS IIIB mice of mixed gender [25,26] at ages
4, 8.5, 12.5, 16, 20.5, 30, and 40 weeks (n=7–10 of each genotype
at each time point; 58 WT and 58 MPS IIIB tested in all). The
mice were dark-adapted for a minimum of 2 hours to obtain
a mixed rod/cone ERG. Mice were anesthetized (80 mg/kg
ketamine, 15 mg/kg xylazine, intra-peritoneal) and positioned
dorsally in a custom head holder. Core temperature was
maintained at 37.561.0uC using a thermostatically-controlled
heating pad controlled by a rectal temperature probe (FHC Inc.,
Bowdoinham, ME). The recording electrode was placed in a drop
of atropine/methylcellulose on the surface of the cornea of the eye,
the reference electrode was inserted subcutaneously at the midline
of the cranium, and a ground electrode was placed subcutaneously
in the back. Mice were exposed to light flashes of 10 ms duration
and an intensity of 76.2 cd*s/m
2. Flash ERG measurements were
recorded on a Tucker-Davis System 3 Complete ABR/OAE
Workstation (Tucker-Davis Technologies, Alachua, FL, USA) and
analyzed using BioSig software. Dark-adapted mixed rod/cone
ERG measurements were determined from the average response
to 5–10 presentations of light at 0.1 Hz. For light-adapted pure
cone ERG measurements, mice were allowed to adapt to light with
an intensity of 72.7 cd/m
2 for 20 min. ERG measurements were
obtained by measuring the average response following 50 light
flashes at a frequency of 1 Hz. Comparisons were made of the b-
wave amplitudes in microvolts (most negative to most positive
points in the trace) from the best of three measurements of each of
the light-adapted and dark-adapted responses, and then averages
were determined for each group of animals. The mean response,
standard deviation, and standard error of the mean were
calculated for each group of genotype and age-matched animals.
Statistical analysis, consisting of two-way ANOVA followed by
Tukey pairwise multiple comparison, was performed using Sigma-
Stat software (SPSS, Chicago, IL).
Retinal histology
Eyes were obtained from wild type (n=1–6) and MPS IIIB (n=1–
6) mice at 4, 8, 12, 16, 20, 30, 34, and 45 weeks of age and
immersion fixed in 2% glutaraldehyde/4% formaldehyde in PBS.
Samples were embedded in Epon-Araldite resin and sectioned into
1-micron-thick sections prior to staining with toluidine blue.
Imaging was obtained by light microscopy.
RESULTS
Motor function & Purkinje cell counts
No performance deficits were observed in the MPS IIIB mice in
either the younger or older cohorts on the common rotarod
measures involving the constant speed or accelerating conditions
across the ages of testing (data not shown). We had included the
rocking rotarod condition in our protocol in an effort to enhance
test sensitivity by increasing the difficulty of the task as a result of
the direction reversal with each rotation of the rod. Use of the
rocking rotarod did not produce performance differences between
groups in the young cohort of mice where the MPS IIIB and
control mice performed almost identically across the different ages
of testing (Fig. 1). However, testing the mice on the rocking
rotarod did lead to performance deficits in the MPS IIIB mice in
the older cohort (Fig. 1). An ANOVA was conducted on the data
from the first four test sessions in the older cohort of mice since we
wanted to assess performance before significant mortality began to
occur. The ANOVA yielded a significant main effect of Genotype,
[F (1, 15)=5.75, p=0.030], and subsequent pairwise comparisons
showed differences were greatest at the second (p=0.013) and
fourth (p=0.034) test sessions when the mice were 244 and 302
days old, respectively. This is well before the average age of death
for the MPS IIIB animals at 315–360 days. Even greater
differences were observed during the fifth and sixth test sessions,
Deficits in Murine MPS IIIB
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this time making the data insufficient for legitimate analyses.
In general correspondence with the age-related impaired
performance on the rocking rotarod test of MPS IIIB mice was
the finding of a diffuse decrease in cerebellar Purkinje neuronal
counts at the vermis (Fig. 2) in older MPS IIIB mice but not in
younger MPS IIIB mice. This age-dependent loss of Purkinje cells
was documented by the results of an ANOVA which yielded
a significant main effect of Age, [F (1,16)=31.15, p,0.001], and
a significant Age by Genotype interaction, [F (1,16)=12.57,
p=0.003]. Other results included a significant effect of Lobe, [F
(7,112)=109.98, p,0.001], a significant Lobe by Genotype
interaction, [F (7,112)=3.00, p=0.010], and a significant Lobe
by Age interaction, [F (7,112=9.53, p,0.001]. Subsequent
contrasts showed that old MPS IIIB mice had, in general,
significantly lower neuronal counts across the cerebellar lobes
compared to their older counterpart controls, [F(1,16)=15.29,
p=0.001], while neuronal counts across cerebellar lobes were not
different between young MPS IIIB mice and young controls.
Pairwise comparisons conducted in the older cohort of mice
showed that differences between groups were greatest in lobes VI
(p=0.001), IV/V (p=0.003), VIII (p=0.004), IX (p=0.011), and
III (p=0.036). To further clarify the age-related Purkinje cell loss,
we compared neuronal counts between older and younger MPS
IIIB mice and found that, in general, the older MPS IIIB mice had
significantly fewer neurons across the cerebellar lobes compared
to the younger MPS IIIB mice, [F(1,16)=46.38, p,0.001], while
no differences were found between older and younger control
mice.
Circadian locomotion & SCN histology
Long-term recordings from MPS IIIB and wild-type mice from
70–250 days of age showed that they both entrain to light-dark
and skeleton light cycles and free-run in constant darkness (Fig. 3).
However, MPS IIIB mice consistently differed from wild-type
mice at all ages examined in their phase angle of entrainment (the
time from the light offset to the onset of daily locomotor activity)
(Fig. 4). MPS IIIB mice started their daily activity approximately
1 h later than wild-type mice (p,0.00001 for the effect of
genotype, but not significant for the effect of age by post hoc
analyses). The percentage of daily activity which occurred during
the light portion of the LD cycle was increased in the MPS IIIB
mice compared to the wild-type mice (2-way ANOVA, p,0.00001
for the effect of genotype; not significant for the effect of age by
post hoc analyses except at the oldest age tested). MPS IIIB mice
did not differ significantly from wild-type mice in period, cycle-to-
cycle period variation, rhythm amplitude, total daily activity, and
duration of daily activity.
In mammals, the suprachiasmatic nucleus (SCN) of the
hypothalamus drives daily rhythms in locomotor activity [27].
Long-term recordings of wheel running in rodents provides a real-
time, non-invasive measure of the state of the SCN, inputs to the
SCN and the ability to synchronize to a light-dark schedule and
control daily rhythms in locomotion. In the SCN of MPS IIIB
mice there are a large number of pyknotic cells (with condensed
nuclei and cytoplasms) suggesting an increase in apoptotic and/or
degenerating neurons. The pyknotic cells contain numerous
distended lysosomes. The majority of neurons in the mutants that
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Figure 1. Older MPS IIIB mice are impaired on the rocking rotarod. Mean duration (in seconds) of the time spent on the rocking rotarod as
a function of increasing ages (days) for MPS IIIB (open squares) and heterozygous (filled diamonds) control mice. No performance differences were
observed between groups on the rocking rotarod in the younger cohort of mice (left panel). In contrast, an ANOVA conducted on the first 4 data
points from the older cohort of mice (right panel) revealed a significant main effect of Genotype (p=0.030), thus showing, in general, that the older
MPS IIIB mice, remained on the rod for a significantly shorter time compared to the heterozygous control mice. Differences between groups were
greatest when the mice were tested at 244 (*p=0.013) and 302 ({p=0.034) days of age. Even greater deficits were observed in the MPS IIIB mice
when they were tested at older ages although small sample sizes resulting from high mortality rates in the MPS IIIB mice precluded formal statistical
analyses. Numbers in parentheses represent sample sizes at specific ages of testing. The dotted line indicates that the last two test sessions (327 and
372 days) were not included in the overall ANOVA since sample sizes were so small due to increased mortality.
doi:10.1371/journal.pone.0000772.g001
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(Fig. 5)
Auditory function & middle and inner ear
histopathology
The C57BL/6 background includes alleles that promote pro-
gressive sensorineural hearing loss [28], therefore both wild type
and MPS IIIB mice show accelerated high frequency (40 kHz)
ABR threshold elevation (Fig. 6). However, the increase in high
frequency ABR thresholds is significantly greater in the MPS IIIB
mice up to 16 wks, at which time background effects begin to
dominate. The fact that initial threshold differences are manifest
only at high frequencies suggests that a sensorineural component
of hearing loss precedes the conductive component. Later emerg-
ence of a conductive component is suggested by the relatively ‘flat’
threshold elevation (i.e., vertically shifted from WT at all
frequencies, but similar audiogram shape) at lower stimulus
frequencies. Presumably both sensorineural and conductive effects
influence thresholds at most frequencies by 16 wks.
Middle ears from MPS IIIB mice at 30 wks of age showed
a combination of storage-related anomalies and highly variable
otitis media, with and without effusion (Fig. 7). Lysosomal storage
was prominent in the mucosal lining and within osteocytes,
chondrocytes, and inflammatory cells (when present). Ossicles
were covered by an extended and thickened mucosal layer
(Fig. 7C, D). Bony surfaces were rough and pitted, suggesting
abnormal bone remodeling. When otitis media with effusion was
present (Fig. 7E, F) inflammatory cells and all cells of the
hypertrophied mucosal lining showed storage. This middle ear
pathology would be expected to alter the mass, stiffness, and
Figure 2. Age-related progressive loss of Purkinje cells in the
cerebellar lobules in MPS IIIB mice. ANOVA of Purkinje cell count by
lobe showed that old MPS IIIB mice (white bars) had significantly lower
neuronal counts across cerebellar lobes compared to old heterozygous
controls (black bars) although differences between groups were lobe
dependent. Pairwise comparisons conducted in the older cohort of
mice showed that differences between groups were greatest in lobes VI
(*p=0.001), IV/V (*p=0.003), VIII (*p=0.004), IX (*p=0.011), and III
(*p=0.036). An ANOVA of the Purkinje cell count data that included
both young and old cohorts of mice resulted in a significant main effect
of Age (p,0.001) and a significant Age by Genotype interaction
(p=0.003). Other important effects included significant Lobe by
Genotype (p=0.010), and Lobe by Age (p,0.001) interactions.
Additional comparisons showed that the older MPS IIIB mice had
significantly fewer neurons across the cerebellar lobes compared to the
younger MPS IIIB mice (p,0.001, (p,0.006, the Bonferroni corrected
value)), while no differences were found between older and younger
control mice.
doi:10.1371/journal.pone.0000772.g002
Figure 3. Locomotor activity records of a representative wild-type
and MPS IIIB mouse. Running wheel revolutions per minute (black
bars) is plotted for 24 h on each line with subsequent days plotted on
the line below. In a light:dark schedule (gray bars show when lights
were on), the mutant mice adjusted rhythm to light similar to wild type
mice. The mice experienced a series of light:dark, dark:dark, and
skeleton photoperiod schedules from ages 70–275 days.
doi:10.1371/journal.pone.0000772.g003
Figure 4. Daily activity in light phase (%) and time (hours) to onset of
activity after light offset. MPS IIIB mice had a greater percentage of
total activity performed during light phases than the WT mice. MPS IIIB
mice also had a longer phase angle of entrainment with a delay in
starting daily activity after lights were turned off of .1 hour. Both
alterations were present from ages 70 to 225 days.
doi:10.1371/journal.pone.0000772.g004
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hearing loss.
Inner ear pathology encompassed a host of cell types in the
cochlea. However, the organ of Corti was largely spared (Fig. 8).
Storage was evident in the spiral ligament (Fig. 8E) (Type II, III,
and IV fibrocytes, and epithelial cells of the spiral prominence), the
spiral limbus (stellate fibrocytes and interdental cells), Reissner’s
membrane (both epithelial and mesothelial cells), and mesothelial
cells lining the bony capsule. No storage was observed within the
stria vascularis. Although spiral ganglion cells did not show
storage, adjacent glial cells frequently did (Fig. 8D). The only
storage noted in the organ of Corti occurred within outer sulcus
cells of the lateral organ (white arrowheads in Fig. 8E) and pillar
cells of the medial organ (black arrow in Fig. 8C). Inflammatory
cells were more likely to appear in the perilymphatic scalae of
mutant mice than wild types (black arrowheads in Fig. 8C), and
often showed storage. By contrast with the organ of Corti, the
vestibular maculae and cristae showed prominent storage in both
supporting cells and hair cells (Fig. 8B), as did dark cells of the
cristae (analogous to cochlear stria marginal cells).
Extensive lysosomal storage throughout the inner ear did not
generally appear to promote degeneration. Nevertheless, our
Figure 5. Suprachiasmatic nuclei (SCN) from wild type and MPS IIIB mice. The SCN of wild type mice contains few if any pyknotic cells with no
observed lysosomal distention. MPS IIIB SCN has numerous pyknotic cells indicated with small black arrows and non-pyknotic cells with distended
lysosomal inclusions indicated by large arrows. Bars indicate 10 micrometers.
doi:10.1371/journal.pone.0000772.g005
Figure 6. Auditory-evoked Brainstem Responses (ABR). Mean (6SEM) ABR thresholds in MPS IIIB and WT mice at 5, 10, 20 and 40 kHz from age 4 to
45 weeks. Earliest differences by genotype appear at high frequencies (40 kHz). By 30 wks, high frequency hearing losses due to background deficits
in C57BL/6 dominate. Threshold differences at lower test frequencies, apparent after 16 wks, probably reflect mixed cochlear and middle ear
pathology. Differences by genotype were significant at all ages (p,.001, 2-way ANOVA).
doi:10.1371/journal.pone.0000772.g006
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loss in the cochlear lower basal turn in MPS IIIB mice. Since this
can also occur due to aging in C57BL/6 mice, mutant and wild
type mice were compared quantitatively. Figure 8G plots hair cell
profiles/radial section versus neuronal density in the lower base for
MPS IIIB and wild type mice at 30 wks of age. Despite the small
sample, there is no overlap of hair cell numbers by genotype and
the difference is significant (t-test, p,0.001). Without exception,
outer hair cell loss was more pronounced than inner hair cell loss,
so that numbers ,1.0 exclusively indicate loss of inner hair cells.
The data indicate that neuronal density decreases only when all
hair cells, including inner hair cells, are lost. Since the vast
majority of spiral ganglion cells innervate inner hair cells, this
suggests that neuronal loss in MPS IIIB occurs secondary to loss of
inner hair cell targets, and that MPS IIIB does not directly
promote neuronal loss. Complete loss of hair cells in the lower base
tended to coincide with wholesale degeneration of the organ of
Corti (Fig. 8F). While this can also be found in comparably aged
C57BL/6 mice, it was much more pronounced in the MPS IIIB
mice.
Retinal function & histology
The dark-adapted retinal response is depressed by 5 weeks in MPS
IIIB mice and becomes progressively less sensitive with increasing
age. The diminished sensitivity reflects a loss of rod function that
becomes statistically significant after 15 weeks. There are no
significant differences at any age in retinal function after light
adaptation suggesting a normal level of cone function. (Fig. 9)
Histological analysis was performed on retinas from control
(n=3–6) and MPS IIIB (n=1–6) mice at 4, 8, 12, 16, 20, 30, 34,
and 45 weeks of age. At 4 weeks of age, the MPS IIIB retina
appeared grossly normal, although localized abnormalities were
seen in retinal pigment epithelium (RPE) cell shape consistent with
loss of cell polarization and/or delamination (not shown). By 8
weeks of age, lysosomal storage could be seen in vascular cells,
Muller glial cells and microglia in the inner retina of MPS IIIB
mice (Fig. 10B) compared to age matched wild type controls
(Fig. 10A). Occasional pyknotic nuclei could be seen in the outer
nuclear layer (ONL) and further disruption in the RPE was seen.
Photoreceptor degeneration, with shortening of the outer segments
and cell loss in the outer nuclear layer, became apparent around 16
weeks (Fig. 10C) with a decrease of 2–4 rows of nuclei by 20 weeks
of age. Macrophage-like cells were apparent in the sub-retinal
space by 16 weeks. Nearly half of the photoreceptor cells were gone
by 30–34 weeks (Fig. 10D) with only 3–4 rows of nuclei remaining
at 45 weeks (not shown). Outer segments are further shortened and
appear swollen. A small population of cells in the ganglion cell layer
began to show pathology by 34 weeks (Fig. 10E). These cells were
usually large and irregularly shaped, with numerous inclusions in
the cytoplasm. The cytoplasm and nucleus of these cells appeared
darker than other cells in the ganglion cell layer.
Large, round, dense melanosome-like structures were seen in
the RPE of MPS IIIB retinas, first becoming noticeable in the
periphery of the mutant eye as early as 4 weeks, distributed
throughout the RPE by 16 weeks, and becoming larger and more
prominent by 30 weeks (Fig. 10D, inset). While melanosomes in
normal retinas were typically ovoid in shape and localized to the
apical cytoplasm, these structures were prominent in the mid to
basal cytoplasm and were distinguished by their round shape.
Although similar small structures were seen in control eyes at 30–
45 weeks, they were seen at younger ages and appeared larger and
more numerous in the mutant eyes. Lysosomal storage was also
seen in the sclera (Fig. 10F, G) and ciliary body (Fig. 10H, I) of
MPS IIIB mice. Inclusions were first apparent by 8 weeks of age
with increasing accumulation and disruption of the tissues by 30
weeks. The ciliary body included round, dense melanosome-like
structures, similar to those seen in the RPE.
DISCUSSION
Motor function and Purkinje cell loss
In humans with MPS IIIB, the loss of ability to walk has long been
described and histological studies have revealed a loss of Purkinje
cells in addition to the accumulation of lysosomal inclusions [9].
The MPS IIIB mouse, as described above, also develops difficulty
with coordination as measured by the rocking rotarod technique,
though the effect is not as dramatic as is seen in humans. Joint
stiffness, which has been described in affected children, may
contribute to changes in motor or sensorimotor functions in the
MPS IIIB mice. However, the lack of performance differences
between MPS IIIB and normal mice between the constant speed
or accelerating conditions of the rotarod test argues against joint
Figure 7. Middle ear pathology. A. Cross-section of stapes (St) with
malleus (M) in WT mouse. B. Higher magnification of rectangular area in
A shows thin mucosal lining and regular bone surfaces. C. Analogous
view to A in an MPS IIIB mouse at age 30 weeks showing thickened
mucosal layer on stapes and malleus (arrow). D. Enlarged view of
rectangular area in C showing hyperplasia of mucosal cells (white
arrows) and lysosomal storage in osteocytes (black arrowheads). Bone
surface is pitted, indicating abnormal bone remodeling. E. Orthogonal
view of stapes in a different MPS IIIB mouse showing otitis media with
effusion. Note hyperplasia of mucosal cells (white arrow) and infiltrate
with inflammatory cells (black arrow). F. Articulation point between
incus and malleus in MPS IIIB mouse showing storage in chondrocytes
(white arrowheads), hyperplasia and storage in mucosal cells (black
arrow), and storage in inflammatory cells (white arrow). SA: Stapedial
artery; F: Footplate of stapes; AL: Annular ligament at point of stapes
insertion into cochlea; TM: Tympanic membrane.
doi:10.1371/journal.pone.0000772.g007
Deficits in Murine MPS IIIB
PLoS ONE | www.plosone.org 7 August 2007 | Issue 8 | e772stiffness as a major source of coordination deficits. The significant
progressive loss of Purkinje cells likely contributes to the
performance deficits on the rocking rotarod, though the additional
contribution of structural and neuronal deficits in the vestibular
apparatus has not been ascertained. However, the absence of
significant Purkinje cell deficits in the archicerebellum is consistent
with a relatively normal central vestibular system. Our assessment
of Purkinje cells was limited to the vermis while the cerebrocer-
ebellum was not assessed. The decrease in neuronal counts seen
near the midline in the paleocerebellum and neocerebellum would
be expected to result in deficits in muscle tone and coordination.
Consistent with this, MPS IIIB mice have a visibly altered posture
and a wide gait, and although coordination performance deficits
were only detectable under the relatively challenging conditions of
the rocking rotarod procedure,theyneverthelessrepresenta measur-
able motor deficit affecting coordination and/or balance. The
deteriorating performance on the rocking rotarod and the pro-
gressive loss of Purkinje cells seen in the MPS IIIB mouse represent
reasonable parallels with the human disease and will serve as
objective measures when evaluating therapeutic interventions.
Figure 8. Inner ear pathology in MPS IIIB mice at 30 wks. A. Radial view of cochlear upper basal turn showing grossly normal features. B. Crista
ampullaris of lateral semicircular canal in the same animal shows abnormal lysosomal storage in both hair cells and supporting cells of the sensory
epithelium (black arrow), and in dark cells (white arrow). C. Expanded view of medial organ of Corti in A. The only cells showing storage are inner
pillar cells (IP) (black arrow). Mesothelial cells lining the basilar membrane (BM) show the aberrant storage (white arrowheads), as do adherent
inflammatory cells (black arrowheads). Vacuoles within inner hair cells (asterisk, IHC) are probably a processing artifact. D. Spiral ganglion cell region
from A shows aberrant storage only in glial cells (white arrowheads). E. Spiral ligament and lateral organ of Corti from A shows aberrant storage in
outer sulcus cells (white arrowhead, OSC), epithelial cells of spiral prominence (black arrowhead, SP), Type III fibrocytes (white arrows, T3), and Type II
fibrocytes (black arrows, T2). Type IV fibrocytes (T4) also showed storage, not apparent in this view. F. Complete loss of hair cells and other
differentiated cell types of the organ of Corti (black arrow), with secondary loss of neuronal processes (white arrow). This was more prevalent in MPS
IIIB mice than in WTs. G. Plot of the number of hair cell profiles versus neuronal density, as seen in radial view in the lower base for 5 MPS IIIB and 5
WT mice at 30 wks. Differences in hair cell numbers by genotype are highly significant (t-test, p,.001). Because inner hair cells were less affected than
outer hair cells, only numbers ,1.0 indicate loss of IHCs. Neuronal density decreases only when IHCs are missing, so that neuronal loss appears
secondary to hair cell loss in MPS IIIB. StV: Stria vascularis; RM: Reissner’s membrane; TM: Tectorial membrane; OHC: Outer hair cells; DC: Deiters’ cells;
OP: Outer pillar cell; Lim: Spiral limbus.
doi:10.1371/journal.pone.0000772.g008
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Sanfilippo syndrome children demonstrate initial hyperactivity
and behavioral disturbances with parents reporting increased
nighttime activity. The children subsequently have diminished
activity levels but retain the nighttime wakefulness. Measuring
MPS IIIB mice using real-time locomotor monitoring during the
progression of lysosomal storage, we found alterations in the
timing of daily locomotor activity at the earliest ages tested. Mice
are normally nocturnal with activity highest during darkness and
reduced activity during the light time. The MPS IIIB mice
demonstrated a significant increase in light phase activity which is
consistent with the increased nighttime activity seen in affected
children [3,29,4,30]. The total activity level did not significantly
differ between MPS IIIB and wild type mice over 70–250 days of
age. A period of hyperactivity was not observed but may have
been missed if it occurred prior to 3 months of age. All mice
showed a normal decrease in activity with increasing age.
Our findings are in contrast to those of prior studies on MPS
IIIB mice [20,21] and further characterize activity levels. One
group tested mice at 2.5 and 4.5 months and found low normal
activity at 2.5 months but significantly diminished activity at 4.5
months. This contrasts with the findings of the second group, who
found normal activity at 5 weeks and increased activity at 29
weeks. Both of these studies tested mice in an open field rather
than a home cage running wheel so activity differences due to
contextual change (novelty) cannot be assessed using our methods,
although our use of longer assessment periods provides a more
accurate index of mouse activity. Both groups also assessed
spontaneously-occurring and conditioned anxiety-like behaviors.
The first group assessed learning in a Pavlovian fear conditioning
test and demonstrated diminished freezing (conditioned anxiety) in
response to a tone that had been paired with shock at the older age
of 4.5 months. However, no differences in freezing were observed
when the mice were placed back into the chamber where they had
previously received tone-shock pairings to assess contextual fear
conditioning. The second group used the elevated plus-maze test
to assess anxiety-like behaviors related to avoidance of open arms
of a maze at 18 and 34 weeks and demonstrated reduced anxiety
response at both ages. The affect of hearing and vision deficits on
anxiety testing was not determined.
MPS IIIB mice showed the greatest activity level changes in the
presence of a light-dark cycle. In constant darkness, the level of
and duration of locomotor activity did not differ between
genotypes. In a light-dark cycle, the fragmented activity during
the light phase and delayed activity onset (phase angle of
entrainment) during the dark phase of MPS IIIB mice indicate
that the disease preferentially targets the pathways responsible for
light responsiveness, with little effect on the mechanisms re-
sponsible for circadian rhythm generation in the SCN. This is
despite the increased numbers of pyknotic neurons and marked
accumulation of inclusions in the cells in the SCN. The
preservation of circadian function despite obvious SCN pathology
supports previous observations that only a small portion of the
SCN suffices to coordinate daily rhythms in locomotion [31]. That
the MPS IIIB mice also become active later than wild-type mice
may indicate deficits in the output pathways from the SCN to
brain areas involved in waking behaviors.
Auditory deficits
Middle and inner ear pathology in MPS III are not well described
in humans or animals. Hearing loss typically appears mixed, while
clear indications of vestibular deficits are not reliably observed
[32,33,34]. Many cochlear cell types showed aberrant lysosomal
storage in MPS IIIB mice, including outer sulcus cells and pillar
cells of the organ of Corti, most fibrocytes of the spiral ligament,
and fibrocytes and interdental cells of the spiral limbus. The wide
variety of cochlear cells affected could alter fluid homeostasis and
the driving force for receptor currents. Although limited lysosomal
storage is found in the organ of Corti in MPS IIIB (none in hair
cells), abnormal lysosomal storage within mesothelial cells lining
Figure 9. Electroretinography. Mixed (cones and rods) photoreceptor b-wave amplitudes (microvolts) to a light stimulus in dark-adapted wild type
(diamonds on dashed line) and MPS IIIB (squares on solid line) mice at ages 4 to 40 weeks demonstrating reduced response in MPS IIIB mice, that is
statistically significant from 16 weeks onward. Cone response b-wave amplitudes after light adaptation is depicted for wild type (open diamond/
dashed line) and MPS IIIB (open square/solid line) at the same ages and shows no difference in cone response.
doi:10.1371/journal.pone.0000772.g009
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elevate hearing thresholds. MPS IIIB mice feature marked
lysosomal storage within receptor and supporting cells of all the
vestibular organs. It remains unclear whether this impacts
vestibular function.
The MPS IIIB mouse demonstrates hair cell loss and organ of
Corti degeneration in the lower cochlear base. If this finding
extends to humans, it holds implications for eventual therapies, in
that such degenerative changes are not reversible. In contrast,
non-degenerative aspects of MPS-related inner ear pathology
appear largely reversible [35,36]. It may also be the case, however,
that abnormal bone remodeling in the middle ear [probably
common to several MPS forms [37,38]] cannot be completely
reversed. The sensorineural hearing loss observed with MPS IIIB
humans [5] is reproduced in the disease phenotype of the MPS
IIIB mouse though the correlative anatomic studies in humans
have not been documented.
Retinal Function
Electroretinography performed in MPS IIIB mice demonstrates
a loss of rod function that correlates with diffuse retinal pathology
including photoreceptor degeneration and vacuolar inclusions in
the retinal pigmented epithelium. Multiple studies of Sanfilippo
children have shown similar abnormalities: diminished to absent
vision with abnormal ERGs [6], photoreceptor degeneration, and
RPE inclusions [7]. In addition, the Sanfilippo children have
inclusions in the retinal ganglion cells, ciliary body and sclera, also
Figure 10. Eye Pathology. Light micrographs showing pathology from normal (A, F, H) and MPS IIIB (B–D, E, G, I) mouse retinas (A–E), sclera (F, G),
and ciliary bodies (H, I). (A) Normal histology from a 4-week old wild type mouse retina is shown and is indistinguishable from older wild type retinas
at 45 weeks. (B) In the 8-week old MPS IIIB mouse retina, aberrant lysosomal storage can be seen in non-neuronal cells in the inner retina (arrow).
Inset: Localized disruption of the retinal pigment epithelium (RPE) from a nearby region of the same retinal section is shown. (C) At about 16 weeks,
the outer segments (OS) of the MPS IIIB mouse are shortened, the outer nuclear layer (ONL) is reduced by 2–4 rows of nuclei, and pyknotic nuclei are
seen in the ONL (arrow). Macrophage-like cells are present in the subretinal space (arrowhead). (D) In the 30-week old MPS IIIB mouse retina, OSs are
further shortened and the ONL is reduced by nearly half. Inset: higher magnification of the boxed area showing dense, round melanosome-like
structures in the RPE. (E) By 34 weeks, a subpopulation of cells in the ganglion cell layer (GCL) has a dense appearance with numerous lysosomal
inclusions in the cytoplasm. (F) Normal histology from a 4-week old wild type mouse sclera is shown. (G) Lysosomal storage appears as pale vesicles in
the sclera of the MPS IIIB mouse (arrowheads). (H) Normal histology from a 4-week old wild type mouse ciliary body is shown. (I) By 30 weeks of age,
the ciliary body of the MPS IIIB mouse appears disorganized and swollen with lysosomal storage vesicles (arrow). Numerous dense, round
melanosome-like structures are seen (arrowhead). IS, photoreceptor inner segments; OPL, outer plexiform layer; INL inner nuclear layer; IPL, inner
plexiform layer. Smaller bar=10 micron for A–D, H, I. Larger bar=10 micron for E–G.
doi:10.1371/journal.pone.0000772.g010
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the ganglion cell layer are particularly interesting in view of the
observed circadian deficits, since ganglion cells rather than
photoreceptors are the primary input to the circadian system
[39]. Inclusions in the lens epithelium, cornea, iris, and trabecular
meshwork are also seen in Sanfilippo children, though we did not
assess for inclusions in these regions of the mouse eye. No mention
is made in the human studies of changes in the thickness of the
outer nuclear layer and outer segments, though these changes may
have been more noticeable in our mice studies due to direct
comparison with normal eyes [6,7,12].
Summary
We demonstrate that the murine model of MPS IIIB develops
progressive deterioration of balance, vision, and hearing. We show
that the development of histological changes in the MPS IIIB
mouse correlates with the functional changes in balance and
vision. We establish that the murine model of MPS IIIB has
similar phenotypic manifestations to those seen in the human
disease with: altered balance and loss of cerebellar neurons;
abnormal sleep patterns and imbalanced day to night activity level;
hearing loss; diminished vision and typical inclusions in the RPE.
The present study describes the progression of phenotypic changes
in the MPS IIIB mouse and sets useful parameters for future
assessment of therapies with the mouse model that are reflective of
the human disease.
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